![David Lye Profile](https://pbs.twimg.com/profile_images/1491056474772041728/2DDvJO2w_x96.jpg)
David Lye
@davidlye70
Followers
503
Following
176
Statuses
162
Infectious disease doctor. Professor, Lee Kong Chian Medicine. Director, Research & Training, National Centre Infectious Diseases. #HighlyCitedResearcher2023
Singapore
Joined March 2014
@edenhelmi But you are probably right. We all know that. Immense harm to patients from unnecessary treatment and missing real diagnosis.
0
0
2
@davidantibiotic The meta analysis even more impressive. All the trials had risk ratio that crossed one, then the meta analysis showed significance for 90 day all cause mortality. The trial is informative. Continuous infusion has marginal clinical benefit.
0
0
1
Please join us by registering with Zoom link and share to your network to learn more about Nipah from @linfa_wang, severe fever with thrombocytopenia syndrome from Professor Dongmin Kim and one health AMR in China from Professor Yonghong Xiao
📢Webinar announcement We invite you to a collaborative webinar with ISAC Member Society, Asia Pacific Society of Clinical Microbiology & Infection (APSCMI) "One health aspects of AMR and infections in Asia" 📅9 May 2024 Register⬇️ #Onehealth #IDxposts
0
6
11
@SetteLab @bertoletti_lab We just went through a large JN.1. Most patients did not have pneumonia or need oxygen. Most hospitalized were frail elderly with minor illness triggered by a viral infection. Real world empirical evidence supports robust cross protective T cells.
6
1
9
Optimising antibiotic use to combat antibiotic resistance starts from right clinical diagnosis followed by right microbiology tests to guide antibiotic use. Feel free to share and use this e-learning module to teach medical students, doctors and any prescribers.
📢NEW Microbiology in Clinical Practice | #Elearning course Sign up for this course by ISAC Member Society, Asia Pacific Society of Clinical #Microbiology and Infection (APSCMI) developed with @biomerieux Access the accredited version ⬇ @davidlye70
0
4
9
@raynerkjtan Do what you can. I used to do one monthly for reputable journals. Now I only review randomised trials in journals with IF>10. That reduces a lot of work. As young faculty you need time to get grants, do research, publish and give lectures so don’t overdo peer review😉.
0
0
3
@edenhelmi @ImeneFelfli @snap_trial @DrSyamhanin @adammashraff Need to follow and use EUCAST P1 not CLSI P10:
0
0
2
@DrToddLee @sebpoule 3B is a lot for city of Quebec…but EPIC has made my outpatient consultations so much better…using smartphrases to pull data…downside is doing the essential clicks but not all clicks are essential
1
0
1
@syctong @snap_trial Ok more controversial than I thought: World Bank rates it as UMIC, Wellcome Trust classifies it as LMIC😅
0
0
1
This follows our work in NEJM in 2021 which has implications for pan-sarbecovirus vaccines and mAb @linfa_wang @CheeWahTan2 @Wanni_Chia
0
0
3